Contact Us
14 May 2019
Posted In

Sibelius engages Canadian lab in cannabis plant study with proprietary Chronoscreen platform

Sibelius Natural Products, the British nutraceutical company, has announced the creation of Seneb Products Limited, a sister Canadian company established in association with a Vulpes-backed Cayman company. As part of the launch, Sibelius has exclusively licensed its Chronoscreen platform to Seneb for the investigation of the cannabis plant.

Peter Leyland, Sibelius CEO, explained: “Over the last 12 months Sibelius has been undertaking its largest ever investigation into the Cannabis plant using the Chronoscreen Platform, however, we have taken our investigative work in the UK as far as we can within the current regulatory framework. This opportunity with Seneb allows us to build on that great work.”

Read the full article on the Nutraceutical Business Review website here.

 

About Sibelius Natural Products
Sibelius is a developer and marketer of high-value, clinically validated natural ingredients for use in dietary supplements, foods and beverages. The company is focused on building modern scientific evidence behind well-known botanicals, helping consumers to make informed decisions about the supplements they choose to purchase. Sibelius’ ingredient portfolio supports unique claims associated with cognition, sleep, anxiety, inflammation, cardiovascular health and men’s health. For more information, please fill in the form below:
Search
Categories
Subscribe to Our Newsletter
Keep up to date with the latest insights
news, events, developments and
product launches

How can we help you?

Please fill in the form below and a member of the team will get back to you. To read our privacy policy, click here.
crossmenu